Richardson, Paul G <br/><br/>
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.  [electronic resource] 

 -  Blood  Nov 2006 
 - 3458-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-04-015909  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Female<br/>Humans<br/>Lenalidomide<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--complications<br/>Peripheral Nervous System Diseases--chemically induced<br/>Recurrence<br/>Remission Induction--methods<br/>Salvage Therapy--adverse effects<br/>Survival Analysis<br/>Survival Rate<br/>Thalidomide--administration & dosage<br/>Venous Thrombosis--chemically induced